Evoke Pharma (EVOK) Misses Q1 EPS by 4c

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41).

As of March 31, 2016, the Company’s cash and cash equivalents were approximately $6.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Morgan Stanley course-corrects their semiconductor equipment outlook on demand
• Investing.com’s stocks of the week